These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9256269)

  • 1. Oligonucleotide therapeutics--novel cardiovascular targets.
    Isner JM
    Nat Med; 1997 Aug; 3(8):834-5. PubMed ID: 9256269
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide.
    Suzuki J; Isobe M; Morishita R; Aoki M; Horie S; Okubo Y; Kaneda Y; Sawa Y; Matsuda H; Ogihara T; Sekiguchi M
    Nat Med; 1997 Aug; 3(8):900-3. PubMed ID: 9256282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense Cdk2 kinase oligodeoxynucleotide inhibits ICAM-1 expression in murine cardiac allograft arteriopathy.
    Suzuki J; Isobe M; Morishita R; Aoki M; Yamazaki S; Kaneda Y; Sawa Y; Matsuda H; Ogihara T; Horie S; Okubo Y; Sekiguchi M
    Transplant Proc; 1998 Feb; 30(1):89-90. PubMed ID: 9474966
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial melanoma and p16--a hung jury.
    Wainwright B
    Nat Genet; 1994 Sep; 8(1):3-5. PubMed ID: 7987389
    [No Abstract]   [Full Text] [Related]  

  • 5. A cell cycle controller rewrites its CV.
    Brooksbank C
    Nat Rev Mol Cell Biol; 2000 Oct; 1(1):3-4. PubMed ID: 11413472
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell proliferation without cyclin E-CDK2.
    Méndez J
    Cell; 2003 Aug; 114(4):398-9. PubMed ID: 12941268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of endothelin expression in allograft coronary arteries after gene therapy targeting Cdk2 kinase.
    Isobe M; Suzuki J; Morishita R; Kaneda Y; Sawa Y; Matsuda H; Ogihara T; Horie S; Okubo Y; Amano J
    Transplant Proc; 1998 Jun; 30(4):1007-8. PubMed ID: 9636407
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cdc2 activation by phosphorylation].
    Yamashita K
    Seikagaku; 1996 May; 68(5):367-71. PubMed ID: 8727661
    [No Abstract]   [Full Text] [Related]  

  • 9. Deregulation of cdc2 gene expression correlates with overexpression of a 110 kDa CCAAT box binding factor in transformed cells.
    Tanimoto A; Kao CY; Chang CC; Sasaguri Y; Padmanabhan R
    Carcinogenesis; 1998 Oct; 19(10):1735-41. PubMed ID: 9806152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin-dependent kinases and cyclin-dependent kinase inhibitors. Detection methods and activity measurements.
    Brooks G
    Methods Mol Biol; 2001; 124():161-70. PubMed ID: 11100474
    [No Abstract]   [Full Text] [Related]  

  • 11. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas.
    Kitahara K; Yasui W; Kuniyasu H; Yokozaki H; Akama Y; Yunotani S; Hisatsugu T; Tahara E
    Int J Cancer; 1995 Jul; 62(1):25-8. PubMed ID: 7601562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase-2 in the birth and death of cardiac muscle cells.
    Schneider MD; MacLellan WR
    Circ Res; 2001 Mar; 88(4):367-9. PubMed ID: 11230100
    [No Abstract]   [Full Text] [Related]  

  • 13. Bared essentials of CDK2 and cyclin E.
    Roberts JM; Sherr CJ
    Nat Genet; 2003 Sep; 35(1):9-10. PubMed ID: 12937419
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression.
    Marone M; Scambia G; Giannitelli C; Ferrandina G; Masciullo V; Bellacosa A; Benedetti-Panici P; Mancuso S
    Int J Cancer; 1998 Jan; 75(1):34-9. PubMed ID: 9426687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer drug targets: cell cycle and checkpoint control.
    Shapiro GI; Harper JW
    J Clin Invest; 1999 Dec; 104(12):1645-53. PubMed ID: 10606615
    [No Abstract]   [Full Text] [Related]  

  • 16. Probing protein-protein interactions with mass spectrometry.
    Kriwacki RW; Siuzdak G
    Methods Mol Biol; 2000; 146():223-38. PubMed ID: 10948505
    [No Abstract]   [Full Text] [Related]  

  • 17. Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2.
    Pomerening JR; Sontag ED; Ferrell JE
    Nat Cell Biol; 2003 Apr; 5(4):346-51. PubMed ID: 12629549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the two-hybrid system to identify protein-protein interaction temperature-sensitive mutants: application to the CDK2/p21Cip1 interaction.
    Cayrol C; Cabrolier G; Ducommun B
    Nucleic Acids Res; 1997 Sep; 25(18):3743-4. PubMed ID: 9278499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two for two: Cdk2 and its role in centrosome doubling.
    Hinchcliffe EH; Sluder G
    Oncogene; 2002 Sep; 21(40):6154-60. PubMed ID: 12214244
    [No Abstract]   [Full Text] [Related]  

  • 20. [Execution of M-phase by Cdc2 kinase].
    Kishimoto T
    Tanpakushitsu Kakusan Koso; 1996 Sep; 41(12 Suppl):1839-46. PubMed ID: 8890645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.